DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Glaucoma – Current Treatment – Current Treatment: Physician Insights – Glaucoma (EU5)
Glaucoma is a progressive disease of the optic nerve caused by high intraocular pressure (IOP); it is one of the leading causes of vision loss in Europe. Treatment of glaucoma aims to lower and…
Dry and Wet Age-Related Macular Degeneration – Emerging Therapies – Special Topics: Novel Therapies in Retinal Diseases (US)
Three anti-VEGF therapies have long been mainstays of treatment in wet age-related macular degeneration (AMD)—Roche / Genentech’s Lucentis, Regeneron’s Eylea, and Roche / Genentech’s…
Glaucoma – Current Treatment – Current Treatment: Physician Insights – Glaucoma (US)
Glaucoma is a progressive disease of the optic nerve, caused by high intraocular pressure (IOP); it is one of the leading causes of vision loss in the United States. Glaucoma treatment aims to…
Dry and Wet Age-Related Macular Degeneration – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of AMD comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed events of AMD for each country, as…
Dry and Wet Age-Related Macular Degeneration – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key AMD patient populations covering 171 countries and more than 99% of…
